Author

S. Pillet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1 Organism:non-human primate· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

A. Prier· 1 shared B. J. Ward· 1 shared B. Pozzetto· 1 shared B. Pulendran· 1 shared C. Dube· 1 shared E. Audoux· 1 shared E. Botelho-Nevers· 1 shared F. Saunier· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Prier

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates

S. Pillet, P. S. Arunachalam, G. Andreani, N. Golden, J. Fontenot, P. Aye, K. Röltgen, G. Lehmick, C. Dube, P. Gobeil, S. Trepanier, N. Charland, M.-A. D'Aoust, K. Russell-Lodrigue, R. V. Blair, , N. Landry

This study evaluates the safety and immunogenicity of a plant-derived VLP vaccine against SARS-CoV-2 in non-human primates, finding that AS03 adjuvanted vaccine provides better protection and immune response.

bioRxiv · May 15, 2021Immunology

Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening

K. Rodriguez, J. Rigaill, E. Audoux, F. Saunier, E. Botelho-Nevers, A. Prier, Y. Dickerscheit, S. Pillet, B. Pozzetto, T. Bourlet, P. O. Verhoeven

This study evaluates copper gluconate's in vitro antiviral activity against SARS-CoV-2 using confocal microscopy-based high content screening and XTT assay for cell viability.

bioRxiv · Dec 13, 2020Microbiology